RE:RE:Speaking factuallybrentkosta wrote: Saying that, those days are all but gone. The hype of building out kilometres of bunk weed are long dead. So now fundamentals slowly take over. However those km's of bunk weed will be extracted and sold at high margins. APH shatter will probably not be as good as FIRE shatter. But who cares. Revs are revs. APH will sell their shatter. Supreme will sell theres. Whats wrong with having a tier system of products? Whats wrong with Supreme having distilate pens? They sell like hot cakes and they have no terps. Why is Supreme stubbornly ignoring a huge market??
Because they are trying to improve margins, not erode them. For a small LP like Supreme, the cost of product developement would hinder their current margins and take focus from what they are good at, growing premium flower.
brentkoska wrote:
There was/is only one cannabis hype. Albeit a few years. It would have behooved FIRE to exploit that hype to their best ability. And raise capital at a much higher multiple. However they failed in doing so. So dilution and poor financiing strategies has hampered us. Quiet behind the scenes growth is NOT how you build a compnay in this industry. Especially when you need to raise money.
brentkoska wrote:
3) Ignoring oils - I get it. You dont need premium bud to make extracts, oils, etc. But why would you ignore the fastest growing portion of this industry? Partner with a large GH grower and extract and dump oils into the market. Ignoring this is a terrible idea. Imagine that once distillate pens are allowed, FIRE wont have any on shelves. HUGE mistake. Instead they will try to tell consumers that shatter and honey oil is better (which it is) but who cares! Give people what they want. Research suggest that distillate pens are a massive hit. Fire wont tap into that market.
They haven't ignored oils, look at their contract with Medipharm Labs. They have also stated the marijuana grown in Lethoso will be used primarily for extracts.
brentkoska wrote:
4) Medical - Supreme used to be Supreme pharmaceuticals. They have absolutely walked away from medical and focused on a tiny domestic rec market. Why do that? Why not have more feathers in your cap? Why ignore cannabis biggest money maker?
They still do medical sales, not sure where you are getting your information. They R/G is a composite of medical and recreational sales.